Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Varian Medical Systems Board of Directors Authorizes Repurchase of Additional 8 Million Shares of St

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media PackNow

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Related stories

Regulatory Compliant EHR Systems Enhancing Data...

An analysis of the critical role of secure, compliant record systems in maintaining the accuracy and sanctity of patient information while navigating the complex global landscape of medical device regulations and privacy standards.

ShiftMed Highlights Open Shift Management Cost...

ShiftMed has released its 2026 Open Shift Management Report,...

UK Medical Device Testing Jumps 17%,...

Clinical investigations of medical devices in the UK reached...

Healthcare Market Reports :- Varian Medical Systems, Inc.today announced that its Board of Directors has authorized the company to repurchase an additional 8 million shares of its common stock during a period commencing immediately and extending through September 30, 2011.  Stock repurchases will be made in the open market, in privately negotiated transactions, or in Rule 10b5-1 share repurchase plans, and may be made from time to time or in one or more larger blocks. 

The repurchase program will be conducted in compliance with the Securities and Exchange Commission’s (SEC) Rule 10b-18 and applicable legal requirements and the timing of the repurchases and the number of shares to be repurchased at any given time will depend on market conditions, SEC regulations, and other factors.  The program does not obligate the company to acquire any particular amount of common stock and the program may be modified or suspended at any time at the company’s discretion.

As of the end of the company’s fiscal third quarter on July 2, 2010, the company had repurchased 3.7 million shares of stock under a 5 million share repurchase authorization that was approved by the board in November of 2009 with an expiration of December 31, 2010.  Since initiating share repurchase authorizations at the end of fiscal year 2001, the company has spent $1.8 billion to repurchase 43 million shares of common stock at an average price of $41.41 per share.

Varian Medical Systems, Inc., of Palo Alto, California, is the world’s leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,200 people who are located at manufacturing sites in North America, Europe, and China and approximately 70 sales and support offices around the world. For more information, visit http://www.varian.com.

FOR INFORMATION CONTACT:

Spencer Sias   (650) 424-5782
   
Spencer.sias@varian.com
   
SOURCE Varian Medical Systems, Inc.

Hospital & Healthcare Management brings together the global healthcare industry โ€” from hospital administrators and clinical directors to health technology innovators and policy leaders โ€” through trusted editorial, market intelligence, and digital engagement.

Our 2026 Media Pack offers integrated solutions to reach your audience:

  • Magazine & Digital Editions Showcase your brand within premium healthcare industry coverage read by executives and decision - makers worldwide.
  • Industry Insights & Reports Align with data - driven analysis, trend reports, and regional roundups across the global hospital and healthcare management value chain.
  • Brand Authority & Credibility Position your company as a thought leader through expert commentary, interviews, and special features.
MEDICAL FAIR ASIA 2026
MEDICAL FAIR CHINA

Latest stories

Related stories

Regulatory Compliant EHR Systems Enhancing Data Integrity

An analysis of the critical role of secure, compliant record systems in maintaining the accuracy and sanctity of patient information while navigating the complex global landscape of medical device regulations and privacy standards.

ShiftMed Highlights Open Shift Management Cost Gap in US

ShiftMed has released its 2026 Open Shift Management Report,...

UK Medical Device Testing Jumps 17%, AI and Neurotech Lead

Clinical investigations of medical devices in the UK reached...

Konica Minolta and deepc AI Partnership Expands Exa Platform

Konica Minolta Healthcare Americas and deepc have formed a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป